DIA
Drug Information Association Logo

Advanced Search

MM-DD-YYYY

Add Filter

    Advanced Search

    Find Meetings & Training 

    Name Start Date Credits Format Region Location
    Clinical Investigator: Module 2 - Conducting the Study Jan 30, 2015 ACPE, CME Online Instruction North America Online
    Clinical Investigator: Module 1 - Study Preparation and Initiation Jan 30, 2015 ACPE, CME Online Instruction North America Online
    Informed Consent Jan 30, 2015 ACPE Online Instruction North America Online
    Crisis Management Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    Database Management Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    Literature Evaluation Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    Literature Searching Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    Medical Inquiries Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    Medical Writing Jan 30, 2015 IACET Online Instruction North America Online
    Product Labeling Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    Regulatory Issues Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    Statistics for Medical Communications Professionals Jan 30, 2015 ACPE, IACET Online Instruction North America Online
    The Use of Mobile Medical Applications as Companions Jan 30, 2015 Online Instruction Global Online
    Generic Drug Labeling Proposed Rule and Safety Updates Jan 30, 2015 Online Instruction Global Online
    Emerging Technologies to Rare Disorder Drug Development: Promises and Pitfalls Jan 30, 2015 Online Instruction Global Online
    Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization Jan 30, 2015 Online Instruction Global Online
    The Role of the Clinical Data Manager Jan 30, 2015 Online Instruction Global Online
    Implementation of the FDASIA Patient Provisions Jan 30, 2015 Online Instruction Global Online
    Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Jan 30, 2015 Online Instruction Global Online
    Variations in the European Union: CMC/Quality Changes Jan 30, 2015 Online Instruction Global Online
    Proarrhythmia Jan 30, 2015 Online Instruction Global Online
    Facets of Drug-Induced Kidney Injury and Regulatory Perspective Jan 30, 2015 Online Instruction Global Online
    Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Jan 30, 2015 Online Instruction Global Online
    Pharmacovigilance and Risk Management: Patient Perspective Jan 30, 2015 Online Instruction Global Online
    Complimentary Patient-Centeredness and Engagement in Clinical Research: Opportunities for Industry Jan 30, 2015 Online Instruction Global Online
    Drug Safety Regulatory Requirements Jan 30, 2015 ACPE, IACET Online Instruction Global Online
    Premarketing Clinical Trial Safety Jan 30, 2015 ACPE, IACET Online Instruction Global Online
    Postmarketing Safety Management Jan 30, 2015 ACPE, IACET Online Instruction Global Online
    Basics of Signal Detection and Pharmacoepidemiology Jan 30, 2015 ACPE, IACET Online Instruction Global Online
    Safety Audits and Inspections Jan 30, 2015 ACPE, IACET Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Jan 30, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Jan 30, 2015 Online Instruction Global Online
    Pharmacovigilance and Global Harmonization Updates Jan 30, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Jan 30, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Jan 30, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Jan 30, 2015 Online Instruction Global Online
    Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies Jan 30, 2015 Online Instruction Global Online
    Negotiation and Influence Jan 30, 2015 Online Instruction Global Online
    Introduction to Drug Safety Jan 30, 2015 ACPE, IACET Online Instruction Global Online
    How to Prepare for a Safety Inspection Jan 30, 2015 Online Instruction Global Online
    Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Jan 30, 2015 Online Instruction Global Online
    Clinical Statistics for Nonstatisticians Jan 30, 2015 Online Instruction Global Online
    Advanced Clinical Statistics for Nonstatisticians Jan 30, 2015 Online Instruction Global Online
    Development of a Clinical Study Report Jan 30, 2015 Online Instruction Global Online
    Art of Writing a Clinical Overview Jan 30, 2015 Online Instruction Global Online
    Introductory Principles and Application of Risk Management within Clinical Operations Jan 30, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Jan 30, 2015 Online Instruction Global Online
    Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate Jan 30, 2015 Online Instruction Global Online
    Disruptive Innovation in Medical Information Jan 30, 2015 Online Instruction Global Online
    A Tour of FDA Jan 30, 2015 Online Instruction Global Online
    A Tour of Health Canada Jan 30, 2015 Online Instruction Global Online
    A Tour of Health Europe Jan 30, 2015 Online Instruction Global Online
    Aspects of Regulatory History Jan 30, 2015 Online Instruction Global Online
    Bioresearch Monitoring Program (BIMO): Introduction Jan 30, 2015 Online Instruction Global Online
    The Clinical Development Process: Investigational Product, Plan, and Data Management Jan 30, 2015 Online Instruction Global Online
    Ethical Review Boards Jan 30, 2015 Online Instruction Global Online
    Ethics as the Foundation to Clinical Research Jan 30, 2015 Online Instruction Global Online
    Awareness of FDA Inspections for Pharmaceutical Manufacturers Jan 30, 2015 Online Instruction Global Online
    Biotechnology: An Overview of Compliance Considerations Jan 30, 2015 Online Instruction Global Online
    Change Control Jan 30, 2015 Online Instruction Global Online
    Clinical Trial Audits and Consequences of Non-Compliance Jan 30, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Medical Device Industry Jan 30, 2015 Online Instruction Global Online
    European Union Clinical Trials Directive Jan 30, 2015 Online Instruction Global Online
    GMP Principals of SOPs Jan 30, 2015 Online Instruction Global Online
    GMP Updates - Enforcement Changes at the New FDA Jan 30, 2015 Online Instruction Global Online
    GMPs for API Bulk Manufacturers Jan 30, 2015 Online Instruction Global Online
    Good Clinical Practices (GCPs) for New Product Investigations Jan 30, 2015 Online Instruction Global Online
    Good Laboratory Practices (GLPs) Jan 30, 2015 Online Instruction Global Online
    GxPs Jan 30, 2015 Online Instruction Global Online
    HIPAA - The Impact on Clinical Research Jan 30, 2015 Online Instruction Global Online
    Introduction to GMPs Jan 30, 2015 Online Instruction Global Online
    Investigational Product Development Jan 30, 2015 Online Instruction Global Online
    ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Jan 30, 2015 Online Instruction Global Online
    Key Concepts of Process Validation Jan 30, 2015 Online Instruction Global Online
    Laboratory Specimens for Clinical Research Jan 30, 2015 Online Instruction Global Online
    Medical Device Safety Reporting Jan 30, 2015 Online Instruction Global Online
    Orientation to GMP Compliance Jan 30, 2015 Online Instruction Global Online
    Overview of the Clinical Research Process Jan 30, 2015 Online Instruction Global Online
    Part 11: Electronic Records and Signatures - Application Jan 30, 2015 Online Instruction Global Online
    Part 11: Electronic Records; Electronic Signatures Jan 30, 2015 Online Instruction Global Online
    Principles of Good Documentation Jan 30, 2015 Online Instruction Global Online
    Protection of Human Subjects in Clinical Trials Jan 30, 2015 Online Instruction Global Online
    Selecting and Managing Clinical Contract Research Organizations (CROs) Jan 30, 2015 Online Instruction Global Online
    Understanding Post-Approval Changes Jan 30, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Pharmaceutical Industry Jan 30, 2015 Online Instruction Global Online
    Basics of the PhRMA Code Jan 30, 2015 Online Instruction Global Online
    Basics of AdvaMed Code Jan 30, 2015 Online Instruction Global Online
    Eucomed Guidelines on Interactions with Healthcare Professionals Jan 30, 2015 Online Instruction Global Online
    Introduction to Medical Device Health Care Compliance Jan 30, 2015 Online Instruction Global Online
    Foreign Corrupt Practices Act Jan 30, 2015 Online Instruction Global Online
    Global Anti-bribery Jan 30, 2015 Online Instruction Global Online
    Variations to Marketing Authorisation in Europe Jan 30, 2015 Online Instruction Global Online
    Registration of Monoclonal Antibodies Jan 30, 2015 Online Instruction Global Online
    How to Gain Approval to Market a Generic Medicinal Product in the USA Jan 30, 2015 Online Instruction Global Online
    Pharmacokinetics and Pharmacodynamics in Drug Registration Jan 30, 2015 Online Instruction Global Online
    Complimentary Quintiles/DIA Webinar - Giving Your Study The Right Start Toward Success Through Optimal Country and Site Selection Jan 30, 2015 Online Instruction Global Online
    Implementing Risk-Based Monitoring: Practical Approaches Jan 30, 2015 Online Instruction Global Online
    Complimentary - Innovative Strategies for Developing Safer Cancer Therapies Jan 30, 2015 Online Instruction Global Online
    Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application Jan 30, 2015 Online Instruction Global Online
    Fundamentals of Project Management for Nonproject Managers Jan 30, 2015 Online Instruction Global Online
    Planning and Managing Your Projects Jan 30, 2015 Online Instruction Global Online
    Preparing a Clinical Trial Budget Jan 30, 2015 Online Instruction Global Online
    Team Building and Development Jan 30, 2015 Online Instruction Global Online
    Pricing, Economic, Reimbursement, Market Share (PERMS) Strategy: An Interactive Holistic Approach in Rare Diseases Jan 30, 2015 Online Instruction Global Online
    Introduction to the European Union Institutions and Regulatory Authority Jan 30, 2015 Online Instruction Global Online
    Introduction to US Institutions and Regulatory Authority (FDA) Jan 30, 2015 Online Instruction Global Online
    Introduction to Japanese Institutions and Regulatory Authorities Jan 30, 2015 Online Instruction Global Online
    Overview of the CTD and eCTD Jan 30, 2015 Online Instruction Global Online
    Introduction to the International Conference on Harmonisation (ICH) Jan 30, 2015 Online Instruction Global Online
    The Regulatory Development of a Drug Jan 30, 2015 Online Instruction Global Online
    Basics of Clinical Trials Jan 30, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Centralized Procedure Jan 30, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Mutual Recognition Procedure Jan 30, 2015 Online Instruction Global Online
    How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Jan 30, 2015 Online Instruction Global Online
    How to Register a New Drug in the USA Jan 30, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Decentralized Procedure Jan 30, 2015 Online Instruction Global Online
    Access to Unapproved Drugs through Compassionate Use Jan 30, 2015 Online Instruction Global Online
    Regulatory Requirements for the Conduct of Clinical Trials in Europe Jan 30, 2015 Online Instruction Global Online
    Orphan Drugs in the USA, European Union, and Japan Jan 30, 2015 Online Instruction Global Online
    Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Jan 30, 2015 Online Instruction Global Online
    Meeting Opportunities with Regulatory Agencies Jan 30, 2015 Online Instruction Global Online
    How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Jan 30, 2015 Online Instruction Global Online
    Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask Jan 30, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Jan 30, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Jan 30, 2015 Online Instruction Global Online
    Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Jan 30, 2015 Online Instruction Global Online
    Adverse Event Reporting Requirements: IND and Postmarketing Jan 30, 2015 Online Instruction Global Online
    Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Jan 30, 2015 Online Instruction Global Online
    The Future of Personalized Medicine and Companion Diagnostics Jan 30, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Jan 30, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Jan 30, 2015 Online Instruction Global Online
    Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Jan 30, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview Jan 30, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Jan 30, 2015 Online Instruction Global Online
    Basics of the IND Jan 30, 2015 Online Instruction Global Online
    Basics of the NDA Jan 30, 2015 Online Instruction Global Online
    Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Jan 30, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Jan 30, 2015 Online Instruction Global Online
    Supplements and Other Changes to an Approved Application Jan 30, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Jan 30, 2015 Online Instruction Global Online
    Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Feb 05, 2015 IACET Online Instruction Global Online
    Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Feb 10, 2015 IACET Online Instruction Global Online
    Bayesian Methods for Drug Safety Evaluation and Signal Detection Feb 10, 2015 IACET In-Person Instruction North America Arlington, VA, United States
    Use of Historical Data in Clinical Trials Feb 10, 2015 IACET In-Person Instruction North America Arlington, VA, United States
    Joint Adaptive Design and Bayesian Statistics Conference: Drivers of Efficiency in Modern Medical Product Development Feb 11, 2015 IACET Meetings North America Arlington, VA, United States
    OPDP/APLB and Compliance 101: A Primer Feb 17, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    Marketing Pharmaceuticals 2015: Drug/Device Marketing in an Evolving Environment Feb 18, 2015 ACPE, IACET Meetings North America Washington, DC, United States
    Art of Writing a Clinical Overview Feb 24, 2015 IACET Online Instruction Global Online
    Introduction to Signal Detection and Data Mining Mar 02, 2015 IACET In-Person Instruction North America Washington, DC, United States
    Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients Mar 03, 2015 Online Instruction Global Online
    Pricing, Economic, Reimbursement, Market Share (PERMS) Strategy: An Interactive Holistic Approach in Rare Diseases Mar 05, 2015 IACET Online Instruction Global Online
    Preparing a Clinical Trial Budget Mar 10, 2015 IACET, PMI Online Instruction Global Online
    Regulatory Affairs: The IND, NDA, and Postmarketing Mar 15, 2015 IACET In-Person Instruction North America Irvine, CA, United States
    Core Curriculum Mar 15, 2015 In-Person Instruction North America Glendale, AZ, United States
    Medical Communications: Compliance in 2015 Mar 16, 2015 In-Person Instruction North America
    Medical & Scientific Communications 2015 Annual Forum Mar 16, 2015 Meetings North America Glendale, AZ, United States
    Premarketing Clinical Safety and Pharmacovigilance Mar 23, 2015 IACET In-Person Instruction North America Washington, DC, United States
    Preparing for a FDA Advisory Committee Meeting Mar 30, 2015 IACET In-Person Instruction North America Washington, DC, United States
    CMC Workshop 2015 Apr 13, 2015 Meetings North America Bethesda, MD, United States
    Regulatory Affairs for Biologics Apr 14, 2015 IACET In-Person Instruction North America Bethesda, MD, United States
    Advanced Signal Detection - Tools, Triage, Evaluation, and Escalation Apr 20, 2015 In-Person Instruction North America Washington, DC, United States
    DIA/FDA Statistics 2015 Forum Apr 20, 2015 Meetings North America North Bethesda, MD, United States
    Key Considerations for the Development and Marketing of Biosimilar Products Apr 27, 2015 In-Person Instruction North America Washington, DC, United States
    Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Apr 29, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    Basics of the IND Phase May 04, 2015 IACET Online Instruction Global Online
    Oversight of Clinical Monitoring: Trends and Strategies May 05, 2015 IACET Online Instruction Global Online
    eRegulatory and Intelligence Annual Conference May 11, 2015 Meetings North America Philadelphia, PA, United States
    Electronic Submissions: The Next Era of Electronic Submissions May 14, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
    Basics of the NDA Phase May 18, 2015 IACET Online Instruction Global Online
    How to Prepare for a Safety Inspection Jun 01, 2015 IACET Online Instruction Global Online
    #20: The Sunshine Act: Understanding the Essentials of Compliance Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #21: Leadership: How to Organize and Lead People in a Work Group Jun 14, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
    #22: Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions, and Regulatory Document Writing Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #23: How to Prepare for an FDA Inspection Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #24: Pharmacogenomics and Companion Diagnostics: The Future of Clinical Trials, New Product Development and the Practice of Medicine Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    DIA 2015 51st Annual Meeting: Develop. Innovate. Advance. Jun 14, 2015 Meetings North America Washington, DC, United States
    #40: Analysis of Safety Data from Clinical Trials Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #41: Quality Oversight of CROs-Clinical Vendors Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #42: Fundamentals of ANDA Submissions and FDA Expectations Under GDUFA Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #43: Clinical Statistics for Nonstatisticians Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #44: Risk Management and Safety Communication Strategies Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #45: The Good Pharmacovigiliance Practices in the EU: Global Applications Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #30: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Affecting Pharmaceutical Development Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #31: Preparing for a US FDA Advisory Committee Meeting Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #32: Influencing Culture, Avoiding Bureaucracy, and Encouraging Innovation Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #33: Large-Scale Regulatory Functional Outsourcing: Emerging Trends, Challenges, and Decision Criteria Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #34: Preparation of Risk Evaluation and Mitigation Strategies Assessment Reports Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #35: Ethical Issues in Clinical Trials Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    Adverse Event Reporting Requirements: IND and Post-marketing Jul 13, 2015 Online Instruction Global Online
    Interactions with the FDA during IND/NDA Phases Jul 16, 2015 Online Instruction Global Online
    Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Aug 10, 2015 ACPE, IACET In-Person Instruction North America Boston, MA, United States
    Development of a Clinical Study Report Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
    Regulatory Affairs: The IND, NDA, and Postmarketing Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
    Clinical Project Management Aug 24, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
    New Drug Product Development and Life Cycle Management Aug 26, 2015 In-Person Instruction North America Washington, DC, United States
    Overview of Drug Development in Japan Sep 02, 2015 Online Instruction Global Online
    DIA/FDA Oligonucleotide-based Therapeutic Conference 2015 Sep 09, 2015 Meetings North America Washington, DC, United States
    Adaptive Design in Clinical Trials: When and How to Apply Sep 14, 2015 In-Person Instruction North America Washington, DC, United States
    Patient Engagement in Benefit-Risk Assessment throughout the Life Cycle of Medical Products Sep 17, 2015 Meetings North America North Bethesda, MD, United States
    Clinical Statistics for Nonstatisticians Sep 28, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    Introduction to Signal Detection and Data Mining Oct 05, 2015 IACET Online Instruction Global Online
    Risk Management and Safety Communication Oct 26, 2015 In-Person Instruction North America Washington, DC, United States
    Postmarketing Drug Safety & Pharmacovigilance Nov 09, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States
    Regulatory Affairs: The IND, NDA, and Postmarketing Nov 09, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
    Navigating Chemistry, Manufacturing and Controls Through the Drug Development Process Nov 09, 2015 In-Person Instruction North America Philadelphia, PA, United States
    Advanced Clinical Statistics for NonStatisticians Nov 11, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States